Degradation assessment of nuclear power plant extraction steam piping after long term service

Degradation due to ageing in a Nuclear Power Plant’s Extraction Steam Piping has been assessed. Samples of twelve years old seamless carbon steel SA 106B pipe have been taken and subjected to metallographic examination, hardness testing, radiographic examination and ultrasonic thickness measurement to investigate and analyze ageing in piping material. Metallographic examination of aged sample revealed irregularly distributed graphite nodules in ferrite grains and on grain boundaries as well, the reduction in pearlite phase has also been observed from 40% to 25%. This Transformation in microstructure has reduced hardness of steel. Reduction in hardness has found 20.4% and 0.7% on inner and outer layer of the pipe material respectively. Corrosion pits having average depth of 0.07 mm have been found on external surface. Radiograph of aged pipe revealed material removal and wall thinning due to erosion on inner surface of pipe. The extent of erosion had been checked, which has found 8.7%

Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial

IMPORTANCE: Liquid biopsy has emerged as a complement to tumor tissue profiling for advanced non-small cell lung cancer (NSCLC). The optimal way to integrate liquid biopsy into the diagnostic algorithm for patients with newly diagnosed advanced NSCLC remains unclear. OBJECTIVE: To evaluate the use of circulating tumor DNA (ctDNA) genotyping before tissue diagnosis among patients with suspected advanced NSCLC and its association with time to treatment. DESIGN, SETTING, AND PARTICIPANTS: This single-group nonrandomized clinical trial was conducted among 150 patients at the Princess Margaret Cancer Centre-University Health Network (Toronto, Ontario, Canada) between July 1, 2021, and November 30, 2022. Patients referred for investigation and diagnosis of lung cancer were eligible if they had radiologic evidence of advanced lung cancer prior to a tissue diagnosis. INTERVENTIONS: Patients underwent plasma ctDNA testing with a next-generation sequencing (NGS) assay before lung cancer diagnosis. Diagnostic biopsy and tissue NGS were performed per standard of care. MAIN OUTCOME AND MEASURES: The primary end point was time from referral to treatment initiation among patients with advanced nonsquamous NSCLC using ctDNA testing before diagnosis (ACCELERATE [Accelerating Lung Cancer Diagnosis Through Liquid Biopsy] cohort). This cohort was compared with a reference cohort using standard tissue genotyping after tissue diagnosis. RESULTS: Of the 150 patients (median age at diagnosis, 68 years [range, 33-91 years]; 80 men [53%]) enrolled, 90 (60%) had advanced nonsquamous NSCLC. The median time to treatment was 39 days (IQR, 27-52 days) for the ACCELERATE cohort vs 62 days (IQR, 44-82 days) for the reference cohort (P \u3c .001). Among the ACCELERATE cohort, the median turnaround time from sample collection to genotyping results was 7 days (IQR, 6-9 days) for plasma and 23 days (IQR, 18-28 days) for tissue NGS (P \u3c .001). Of the 90 patients with advanced nonsquamous NSCLC, 21 (23%) started targeted therapy before tissue NGS results were available, and 11 (12%) had actionable alterations identified only through plasma testing. CONCLUSIONS AND RELEVANCE: This nonrandomized clinical trial found that the use of plasma ctDNA genotyping before tissue diagnosis among patients with suspected advanced NSCLC was associated with accelerated time to treatment compared with a reference cohort undergoing standard tissue testing

Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.

IMPORTANCE Liquid biopsy has emerged as a complement to tumor tissue profiling for advanced non-small cell lung cancer (NSCLC). The optimal way to integrate liquid biopsy into the diagnostic algorithm for patients with newly diagnosed advanced NSCLC remains unclear. OBJECTIVE To evaluate the use of circulating tumor DNA (ctDNA) genotyping before tissue diagnosis among patients with suspected advanced NSCLC and its association with time to treatment. DESIGN, SETTING, AND PARTICIPANTS This single-group nonrandomized clinical trial was conducted among 150 patients at the Princess Margaret Cancer Centre-University Health Network (Toronto, Ontario, Canada) between July 1, 2021, and November 30, 2022. Patients referred for investigation and diagnosis of lung cancer were eligible if they had radiologic evidence of advanced lung cancer prior to a tissue diagnosis. INTERVENTIONS Patients underwent plasma ctDNA testing with a next-generation sequencing (NGS) assay before lung cancer diagnosis. Diagnostic biopsy and tissue NGS were performed per standard of care. MAIN OUTCOME AND MEASURES The primary end point was time from referral to treatment initiation among patients with advanced nonsquamous NSCLC using ctDNA testing before diagnosis (ACCELERATE [Accelerating Lung Cancer Diagnosis Through Liquid Biopsy] cohort). This cohort was compared with a reference cohort using standard tissue genotyping after tissue diagnosis. RESULTS Of the 150 patients (median age at diagnosis, 68 years [range, 33-91 years]; 80 men [53%]) enrolled, 90 (60%) had advanced nonsquamous NSCLC. The median time to treatment was 39 days (IQR, 27-52 days) for the ACCELERATE cohort vs 62 days (IQR, 44-82 days) for the reference cohort (P < .001). Among the ACCELERATE cohort, the median turnaround time from sample collection to genotyping results was 7 days (IQR, 6-9 days) for plasma and 23 days (IQR, 18-28 days) for tissue NGS (P < .001). Of the 90 patients with advanced nonsquamous NSCLC, 21 (23%) started targeted therapy before tissue NGS results were available, and 11 (12%) had actionable alterations identified only through plasma testing. CONCLUSIONS AND RELEVANCE This nonrandomized clinical trial found that the use of plasma ctDNA genotyping before tissue diagnosis among patients with suspected advanced NSCLC was associated with accelerated time to treatment compared with a reference cohort undergoing standard tissue testing. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT04863924

Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF)

&lt;p&gt;Aims: This report describes the baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) which is testing the hypothesis that anaemia correction with darbepoetin alfa will reduce the composite endpoint of death from any cause or hospital admission for worsening heart failure, and improve other outcomes.&lt;/p&gt; &lt;p&gt;Methods and results: Key demographic, clinical, and laboratory findings, along with baseline treatment, are reported and compared with those of patients in other recent clinical trials in heart failure. Compared with other recent trials, RED-HF enrolled more elderly [mean age 70 (SD 11.4) years], female (41%), and black (9%) patients. RED-HF patients more often had diabetes (46%) and renal impairment (72% had an estimated glomerular filtration rate &#60;60 mL/min/1.73 m2). Patients in RED-HF had heart failure of longer duration [5.3 (5.4) years], worse NYHA class (35% II, 63% III, and 2% IV), and more signs of congestion. Mean EF was 30% (6.8%). RED-HF patients were well treated at randomization, and pharmacological therapy at baseline was broadly similar to that of other recent trials, taking account of study-specific inclusion/exclusion criteria. Median (interquartile range) haemoglobin at baseline was 112 (106–117) g/L.&lt;/p&gt; &lt;p&gt;Conclusion: The anaemic patients enrolled in RED-HF were older, moderately to markedly symptomatic, and had extensive co-morbidity.&lt;/p&gt

Cultural difference on the table: food and drink and their role in multicultural team performance

Multicultural teams are increasingly common and provide a challenge to achieving the integration associated with greater effectiveness. The vague and abstract nature of many definitions of culture can make the difficulties in acknowledging and addressing difference challenging. This longitudinal study of a multicultural team follows the anthropological roots of cultural studies to focus on the material role of food and drink in team development. In an empirical, ethnographically oriented study of a culturally diverse work team over time, we explored the ways that food and drink acted as boundary objects in the processes of integration, differentiation and cultural adaptation and negotiation. By employing the lens of material culture, with its sensory nature and its associations with identity, we also highlight the complexity of cross-cultural interaction, with its possibilities of cooperation, learning, difficulties and resistance, and suggest that food and drink allow a grounded discussion of culture, accommodation and difference. We contribute to the multicultural team literature, emphasizing the roles of materiality, constrained choice and complexity, as well as how these are translated into performance by the generative mechanisms of agency in context. We also identify some specific contributions to practice arising from this research

Probing swift heavy ion irradiation damage in Nd-doped zirconolite

Synroc minerals have been studied since decades for immobilization of high-level radioactive wastes released from nuclear weapons and nuclear reactors. Among them, the zirconolite, due to its high radiation and aqueous resistance and high waste loading, is considered as a potential candidate for containment purposes. Though irradiation damage effects of swift heavy ions in the material remain a major concern of study, a single phase Nd-doped zirconolite samples prepared through conventional solid-state reaction were irradiated with 120 MeV Au+ ions to study radiation damage effects. Irradiation-induced effects were investigated using ex-situ XRD and micro-Raman spectroscopic techniques. Zirconolite has been observed to undergo amorphization which is confirmed through disappearance of characteristic x-ray diffraction peaks and appearance of broad diffuse scattering bands. Amorphization trend with fluence appeared linear at lower fluences followed by saturation at higher fluences inferring therewith the formation of ion tracks. The ion fluence dependent Raman examination was also found to be in line with the XRD observations. However, the presence of Raman modes, characteristic of zirconolite in the 100–1000 cm−1 region, showed intact behavior of the local structure. To sum up, the 120 MeV heavy Au+ ions developed columnar defects, vacancies and induced micro-strains that lead to the bonds distortion and eventually amorphization of the zirconolite though retaining local ordering